Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
7.96
+0.13 (1.66%)
At close: Aug 4, 2025, 4:00 PM
8.03
+0.07 (0.88%)
After-hours: Aug 4, 2025, 7:41 PM EDT
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of $2.49 billion as of August 4, 2025. Its market cap has increased by 10.42% in one year.
Market Cap
2.49B
Enterprise Value
5.01B
1-Year Change
10.42%
Ranking
Category
Stock Price
$7.96
Market Cap Chart
Since March 27, 2018, Amneal Pharmaceuticals's market cap has decreased from $5.76B to $2.49B, a decrease of -56.69%. That is a compound annual growth rate of -10.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 2.49B | 1.66% |
| Dec 31, 2024 | 2.45B | 31.89% |
| Dec 29, 2023 | 1.86B | 208.01% |
| Dec 30, 2022 | 604.10M | -58.17% |
| Dec 31, 2021 | 1.44B | 5.42% |
| Dec 31, 2020 | 1.37B | -4.99% |
| Dec 31, 2019 | 1.44B | -64.31% |
| Dec 31, 2018 | 4.04B | -29.87% |
| Mar 27, 2018 | 5.76B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 690.36B |
| Johnson & Johnson | 411.92B |
| AbbVie | 348.32B |
| AstraZeneca | 229.32B |
| Novartis AG | 226.38B |
| Abbott Laboratories | 226.14B |
| UnitedHealth Group | 218.60B |
| Novo Nordisk | 215.34B |